STATE OF NEW JERSEY VS. R.G. (17-04-0189, SOMERSET COUNTY AND STATEWIDE) (RECORD IMPOUNDED) ( 2019 )

RECORD IMPOUNDED
NOT FOR PUBLICATION WITHOUT THE
APPROVAL OF THE APPELLATE DIVISION
SUPERIOR COURT OF NEW JERSEY
APPELLATE DIVISION
DOCKET NO. A-3090-18T3
STATE OF NEW JERSEY,
Plaintiff-Appellant, APPROVED FOR PUBLICATION
July 31, 2019
v.
APPELLATE DIVISION
R.G.,
Defendant-Respondent.
____________________________
Argued June 4, 2019 – Decided July 31, 2019
Before Judges Fisher, Suter and Enright.
On appeal from an interlocutory order of the Superior
Court of New Jersey, Law Division, Somerset County,
Indictment No. 17-04-0189.
Paul Henry Heinzel, Assistant Prosecutor, argued the
cause for appellant (Michael H. Robertson, Somerset
County Prosecutor, attorney; Paul Henry Heinzel, of
counsel and on the briefs).
Joseph J. Russo, Deputy Public Defender, argued the
cause for respondent (Joseph E. Krakora, Public
Defender, attorney; Joseph J. Russo, on the brief).
Alexander R. Shalom argued the cause for amicus
curiae American Civil Liberties Union of New Jersey
(American Civil Liberties Union of New Jersey
Foundation, attorneys; Alexander R. Shalom and
Jeanne M. Locicero, on the brief).
The opinion of the court was delivered by
SUTER, J.A.D.
The State appeals the January 7, 2019 order of the trial court that denied
its request for an order to involuntarily medicate defendant R.G. to restore him
to competency to stand trial. We affirm the trial court's order. We agree with
the trial court that the State did not satisfy the test under Sell v. United States,
539 U.S. 166 (2003), because the first factor is determined by consideration of
defendant's probable sentence not simply the maximum sentence exposure for
the offense charged. The trial court also must consider the potential effect of
the medication on defendant's right to a fair trial when applying Sell. Because
the Sell test was not satisfied, we have no occasion to determine whether our
State Constitution would afford a defendant greater protection of individual
liberty or privacy rights.
I
Defendant's mother was attending a wedding in California when she asked
the police to check on her husband's welfare because she had not heard from
him. Defendant answered the door when the police arrived dressed only in a
blanket. The police inquired about his father. Defendant pointed to the floor
where his father was lying. A pool of blood was near his father's mouth. He
A-3090-18T3
2
had vomit on his face, was breathing but with difficulty, and had a mild pulse.
There were no visible signs of trauma. Defendant told the police his father had
been laying there for about twelve to twenty-four hours. Defendant was waiting
to summon help because his father had a similar gastrointestinal bleed in the
past and recovered. Defendant also told the police illogical things about
developing weapons for the government. Defendant's father died at the hospital
the next day of natural causes.
Defendant was charged with third-degree neglect of an elderly or disabled
person, N.J.S.A. 2C:24-8(a). He remained in jail from mid-December 2016 until
the end of May 2017, when his bail was reduced and he was released. More
than eight months later, and following a request by his attorney, the trial judge
entered an order under N.J.S.A. 2C:4-5(a)(2) that required defendant to take a
fitness to proceed (competency) examination. The examining psychologist
recommended conducting the examination in a hospital.
On June 1, 2018, defendant was remanded to the Somerset County Jail
without bail and later admitted to Trenton Psychiatric Hospital (TPH) for the
competency evaluation that was conducted in October 2018. He was found not
competent to stand trial. To our knowledge, he remains a patient at TPH.
A-3090-18T3
3
In October 2018, the State filed a motion for an order to require defendant
to be involuntarily medicated because defendant refused to take antipsychotic
medication voluntarily. The State claimed it had an important interest in
restoring defendant to competence, that he would likely become competent with
medication and that medication was in his best interest.
At the competency hearing in December 2018, Dr. Jonathan L. Rapaport,
a forensic psychologist, testified, based on his examination, that defendant had
a delusional disorder and psychosis because he believed his father was still alive
even though he had been shown the autopsy photographs. Defendant's mental
illness was impairing his ability to assist his attorney with a defense. Dr.
Rapaport testified defendant was not competent to stand trial.
He recommended steps to restore defendant to competency: defendant
should attend a competency restoration group at TPH to assist in understanding
the legal process and take antipsychotic medication. Dr. Rapaport opined that
medication would "help greatly" to alleviate defendant's psychosis and "very
likely" improve defendant's mental state. Defendant was not participating in
any groups at TPH. Although defendant remained competent to decide his own
medical issues, he was refusing to take any antipsychotic medication.
A-3090-18T3
4
Dr. Rapaport testified the medication was a necessary treatment for
defendant and the lack of medication was preventing him from becoming
competent to stand trial. He claimed that defendant "possibly" was a danger to
himself or others because he had become physically agitated when they were
discussing the medication issue, and because he allegedly had a history of
assault and domestic violence. Dr. Rapaport testified that medication would
help defendant's delusions "to gradually dissipate" although there was "no
guarantee." Defendant's psychosis was severe. Dr. Rapaport was of the view
that although defendant's participation in group therapy would be helpful,
antipsychotic medication was "necessary."
Dr. Yves George Dubois, an attending psychiatrist at TPH, also examined
defendant. He testified that defendant did not have the mental capacity to stand
trial. Defendant had a delusional disorder with a "disorganized" thought process
and "bizarre" thinking. With this "chronic psychosis," defendant was "losing
brain cells" that eventually could impair his memory and affect his activities of
daily living. Defendant could become dangerous. Dr. DuBois recommended
that defendant take medications such as Haldol or Prolixin to gain competence
to proceed to trial and for his mental health. Either medication was medically
appropriate for his condition. Because Prolixin could cause a rise in "blood
A-3090-18T3
5
pressure, weight gain [and] diabetes," Dr. Dubois recommended prescribing
Haldol.
He testified that both antipsychotic medications could cause "abnormal
movement, like shaking, tremors" and "rigidity," but there were other
medications to control that. In his opinion, the side effects from the medication
would not undermine the fairness of a trial. For drowsiness, he suggested
decreasing the dosage. He testified the medication would not prevent
defendant's rapid reaction to events that happened on the stand. Dr. Dubois
acknowledged that Haldol could decrease defendant's ability to express
emotions, but he testified, "we have other medication to counteract that and we
can also decrease the dosage."
Dr. Dubois testified that defendant was becoming more delusional
although he was not declining cognitively, meaning that defendant could
appreciate the necessity to take medication to improve his life. He was not
violent. He did not pose an imminent danger at TPH. Because of this, Dr.
Dubois could not administer the antipsychotic medication without defendant's
consent or a court order.
Dr. Dubois testified it was in defendant's best medical interest to take the
medication. He thought there was a reasonable probability the medication
A-3090-18T3
6
would enable defendant to participate in a trial. In his view, therapy alone would
not be enough.
The trial court continued defendant's commitment at TPH for another
ninety days.1 With respect to the State's pending motion to involuntarily
medicate defendant, the parties were ordered to submit additional briefing on
whether there was an important government interest at stake that would require
defendant's involuntary medication. The court noted the doctors both testified
that medication would likely restore defendant to competency, and that
medication was necessary and was medically appropriate.
On January 7, 2019, the trial court denied the State's motion to medicate
defendant involuntarily. In its written opinion, the trial court applied the four
factors outlined by the Supreme Court in Sell, even though it was "hesitan[t] to
allow for the practice of involuntary medication of defendants for restoration in
the absence of any clear authority in New Jersey," and because it questioned the
constitutionality of the practice under our State's Constitution. Nonetheless, the
trial court found the State had not proven it had an important governmental
1
A subsequent competency review hearing was held on March 28, 2019, where
the court declined to dismiss the charges at that time. See N.J.S.A. 2C:4-6(c)
(providing that where a defendant "has not regained his fitness to proceed within
three months, the court shall hold a hearing on the issue of whether the charges
against him shall be dismissed with prejudice or held in abeyance").
A-3090-18T3
7
interest at stake as required by the first factor under Sell, 539 U.S. at 180. The
trial court reasoned that defendant had a presumption of non-incarceration,
having been charged with a third-degree offense and having no prior
convictions,2 and "would likely receive a probationary sentence if convicted."
Moreover, the court noted that defendant had been at TPH longer than his likely
sentence if convicted. His "charges appear[ed] to have stemmed from the nature
of his delusions" and he may have been "suffering from a psychotic episode at
the time." Defendant also remained subject to confinement at TPH. All of these
factors lessened the governmental interest to the point that the court would not
order involuntary medication. The court found that the other factors under Sell
had been established.
The State filed a motion for leave to appeal. While that was pending, the
trial court supplemented its written decision to address issues and cases the State
presented in its motion for leave to appeal, which it had not raised earlier. The
court did not agree with the State's argument that the first factor under Sell—the
importance of the State's interest—should be determined based solely on the
maximum sentence authorized for the offense charged. The court rejected this
in favor of a probable sentence approach because New Jersey's Constitution
2
See N.J.S.A. 2C:44-1(e).
A-3090-18T3
8
"generally affords greater protections of an individual's liberty than provided for
in the Federal Constitution." The State newly argued that defendant's crime
constituted an act of domestic violence and that a presumption of incarceration
applied. The court rejected the argument that all crimes of domestic violence
would satisfy the seriousness factor under Sell, opting instead for a case-by-case
approach. The State did not present evidence that defendant was convicted of
domestic violence in the past, which rendered aggravating factor fifteen 3
inapplicable to this case. The trial court concluded that even if the new
arguments by the State had been made previously, "they would not have been
determinative of the outcome of the State's motion."
In March 2019, we granted the State leave to appeal the trial court's
January 7, 2019 order, and allowed supplemental briefing. We subsequently
granted the American Civil Liberties Union of New Jersey's request to
participate as amicus curiae.
On appeal, the State argues that it has a great interest in prosecuting this
case. It contends it has satisfied all the required factors under Sell for an order
3
Reference is to N.J.S.A. 2C:44-1(a)(15) (providing that an aggravating
circumstance for sentencing is an offense constituting an act of domestic
violence and "the defendant committed at least one act of domestic violence on
more than one occasion").
A-3090-18T3
9
to medicate defendant involuntarily to restore him to competence to stand trial.
Amicus curiae argues that defendant has a significant liberty interest in bodily
integrity protected by both the Federal and State Constitutions; that the State
Constitution prohibits any forced medication of a non-dangerous defendant just
to restore him to competency to stand trial; and that in determining whether to
involuntarily medicate defendant, the trial court must take into consideration the
impact that medication will have on defendant's right to a fair trial.
II
A
We consider this issue in the context of decisions by the United States
Supreme Court that have addressed the issue of involuntary medication of
prisoners with mental illness. In Washington v. Harper, 494 U.S. 210 (1990), a
Washington State regulation allowed for the involuntary medication of a
convicted offender when "the mentally ill inmate [was] 'gravely disabled' or
. . . present[ed] a 'serious likelihood of harm' to himself or others . . . ." Id. at
220. In affirming the regulation against a due process challenge, the Court
recognized that Harper had a "significant liberty interest in avoiding the
unwanted administration of antipsychotic drugs under the Due Process Clause
of the Fourteenth Amendment." Id. at 221-22 (citing Vitek v. Jones, 445 U.S.
A-3090-18T3
10
480, 491-94 (1980); Youngberg v. Romeo, 457 U.S. 307, 316 (1982); Parham v.
J.R., 442 U.S. 584, 600-01 (1979)). The Court observed that "[t]he forcible
injection of medication into a nonconsenting person's body represents a
substantial interference with that person's liberty." Id. at 229 (citing Winston v.
Lee, 470 U.S. 753 (1985); Schmerber v. California, 384 U.S. 757, 772 (1966)).
It also took note of the possible side effects of the medications. 4 After
considering the competing individual and State interests, the Court held that
"given the requirements of the prison environment, the Due Process Clause
permits the State to treat a prison inmate who has a serious mental illness with
antipsychotic drugs against his will, if the inmate is dangerous to himself or
others and the treatment is in the inmate's medical interest." Id. at 227. The
Court found that the procedures under the regulation afforded the inmate
adequate procedural due process. Id. at 228.
In Riggins v. Nevada, 504 U.S. 127 (1992), a defendant appealed his
conviction for murder and robbery, claiming a due process violation because he
4
These can include "acute dystonia, a severe involuntary spasm of the upper
body, tongue, throat, or eyes"; "akathesia (motor restlessness, often
characterized by an inability to sit still); neuroleptic malignant syndrome (a
relatively rare condition which can lead to death from cardiac dysfunction)"; and
"[t]ardive dyskinesia . . . a neurological disorder, irreversible in some cases, that
is characterized by involuntary, uncontrollable movements of various muscles,
especially around the face." Id. at 229-30.
A-3090-18T3
11
was required to take certain psychotropic medications during his trial although
he had requested to terminate their administration. Riggins claimed he was
denied due process because of the effect of the drugs on his demeanor and mental
state during trial, while the State contended the drugs were needed to maintain
his competence to stand trial. Id. at 133.
The Court considered its decision in Harper that "forcing antipsychotic
drugs on a convicted prisoner is impermissible absent a finding of overriding
justification and a determination of medical appropriateness," and concluded
that the "Fourteenth Amendment affords at least as much protection to persons
the State detains for trial." Id. at 135 (citing Bell v. Wolfish, 441 U.S. 520, 545
(1979); O'Lone v. Estate of Shabazz, 482 U.S. 342, 349 (1987)). Had the State
proven "that treatment with antipsychotic medication was medically appropriate
and, considering less intrusive alternatives, essential for the sake of Riggins'
own safety or the safety of others," it would have satisfied due process. Ibid.
(citing Harper, 494 U.S. at 225-26; Addington v. Texas, 441 U.S. 418 (1979)).
The Court reversed the convictions because the trial court failed to make
adequate findings to support "the need for this [medication and did not make]
any findings about reasonable alternatives." Id. at 136. It also did not make
findings that "safety considerations or other compelling concerns outweighed
A-3090-18T3
12
Riggins' interest in freedom from unwanted antipsychotic drugs." Ibid. This
may have infringed upon his right to a fair trial, noting that the side effects from
the drugs may have "had an impact upon not just Riggins' outward appearance,
but also the content of his testimony on direct or cross examination, his ability
to follow the proceedings, or the substance of his communication with counsel."
Id. at 137. The Court held that "[b]ecause the record contain[ed] no finding that
might support a conclusion that administration of antipsychotic medication was
necessary to accomplish an essential state policy," the Court had "no basis . . .
for saying that the substantial probability of trial prejudice in this case was
justified." Id. at 138.
In a concurring opinion, Justice Kennedy voiced concerns about the
effects of the drugs on a defendant's right to a fair trial, expressing that the "side
effects seems to me to render involuntary administration of the drugs by
prosecuting officials unacceptable absent a showing by the State that the side
effects will not alter the defendant's reactions or diminish his capacity to assist
counsel." Id. at 143 (Kennedy, J., concurring).
B
The Court addressed the issue of involuntary medication—this time for a
defendant who was not convicted—in the Sell case. 539 U.S. at 166. Sell was
A-3090-18T3
13
charged with mail fraud, Medicaid fraud, money laundering and attempted
murder. Id. at 170. He was found not competent to stand trial. Id. at 171. The
State recommended that he take antipsychotic medication to restore him to
competency to proceed. Ibid. When he refused, the State sought permission
from the court to require Sell to be involuntarily medicated. Ibid.
In Harper and Riggins, the Supreme Court noted that:
the Constitution permits the [g]overnment involuntarily
to administer antipsychotic drugs to a mentally ill
defendant facing serious criminal charges in order to
render that defendant competent to stand trial, but only
if the treatment is medically appropriate, is
substantially unlikely to have side effects that may
undermine the fairness of the trial, and, taking account
of less intrusive alternatives, is necessary significantly
to further important governmental trial-related
interests.
[Id. at 179.]
The Court identified four factors that had to be satisfied before a court
could order involuntary medication to restore a defendant to competency to
stand trial for serious, but nonviolent crimes. Id. at 180-81.
"First, a court must find that important governmental interests are at stake.
The [g]overnment's interest in bringing to trial an individual accused of a serious
crime is important." Id. at 180. The Court said, however, that "special
circumstances" might lessen the importance of the State's interest. Ibid. These
A-3090-18T3
14
could include the length a defendant has been confined because that "would
diminish the risks that ordinarily attach to freeing without punishment one who
has committed a serious crime." Ibid. A lengthy confinement may also make it
difficult to prosecute a defendant. Ibid. The "potential for future confinement"
and the length of time a defendant had been confined, "for which he would
receive credit toward any sentence ultimately imposed . . . ." all affected the
State's interests. Ibid. The Court recognized the State "has a concomitant,
constitutionally essential interest in assuring that the defendant 's trial is a fair
one." Ibid.
The second Sell factor requires a trial court to conclude that involuntary
medication "is substantially likely to render the defendant competent to stand
trial" and that it "is substantially unlikely to have side effects that will interfere
significantly with the defendant's ability to assist counsel in conducting a trial
defense, thereby rendering the trial unfair." Id. at 181 (citing Riggins, 504 U.S.
at 142-45 (Kennedy, J., concurring)).
The third factor requires the State to show that medication is "necessary
to further those interests" and that "less intrusive treatments are unlikely to
achieve substantially the same results." Ibid.
A-3090-18T3
15
The fourth factor requires the trial court to "conclude that administration
of the drugs is medically appropriate, i.e., in the patient's best medical interest
in light of his medical condition." Ibid.
The Court made clear that the instances where these factors would be met
"may be rare."5 Id. at 180. Because they were not satisfied in Sell, the Court
reversed the order that required involuntary medication and remanded the case.
Id. at 186.
The Court emphasized the concerns it had raised in Riggins about the
effects of antipsychotic medication. "Whether a particular drug will tend to
sedate a defendant, interfere with communication with counsel, prevent rapid
reaction to trial developments, or diminish the ability to express emotions are
matters important in determining the permissibility of medication to restore
competence . . . ." Id. at 185 (citing Riggins, 504 U.S. at 142-45 (Kennedy, J.,
concurring)). The Court remanded Sell to the trial court for consideration of
these factors.
5
Sell does not expressly address the evidentiary standard needed to establish
the four factors. Because the Court said the factors would be satisfied rarely,
we agree with United States v. Gomes, 387 F.3d 157, 160 (2d Cir. 2004), that
the Sell "findings must be supported by clear and convincing evidence."
A-3090-18T3
16
III
We have not previously addressed whether a defendant charged with a
crime, who is not competent to stand trial but who is competent to make medical
decisions and has refused to take antipsychotic medication, can be involuntarily
medicated to restore competency to stand trial.
The issue was addressed only briefly in a Law Division opinion. State v.
Otero, 238 N.J. Super. 649 (Law Div. 1989). And, while we are mindful other
states have enacted legislation to guide trial courts in these situations, 6 New
Jersey has not. Nevertheless, because we are satisfied the State's application to
compel medication here fails under the Sell test, we need not determine whether
our State Constitution provides greater individual protection than does the
Federal Constitution described in Sell. Instead, we reject the State's arguments
because we agree with the trial judge's determination that Sell's first factor is
not informed by defendant's maximum exposure but by defendant's probable
sentence if convicted. A trial court, in applying the Sell test, should also
6
Cal. Penal Code § 1370 (California); Colo. Rev. Stat. § 16-8.5-112 (Colorado);
Conn. Gen. Stat § 54-56d (Connecticut); 405 Ill. Comp. Stat. Ann. 5/2-107.1
(Illinois); Me. Rev. Stat. Ann. tit. 15 § 106(3)-(4) (Maine); Md. Code Ann.
Health-Gen. § 10-708(b) (Maryland); Ohio Rev. Code. Ann. § 2945.38(B)(1)(C)
(Ohio); Or. Rev. Stat. Ann. 2945.38 (Oregon); VT. Stat. Ann. tit. 18 § 7629
(Vermont); Wash. Rev. Code Ann. § 10.77.092 (Washington); Wis. Stat. Ann.
§ 971.17(3)(c) (Wisconsin); Wyo. Stat. Ann. § 7-11-303(e) (Wyoming).
A-3090-18T3
17
consider the effects of the medication on a defendant's right to a fair trial.
Medical experts should testify about how the medication is likely to affect a
defendant's ability to communicate with counsel, to testify, to react rapidly to
events in the trial, and to express emotions before the jury. See Sell, 539 U.S.
at 185; see also Riggins, 504 U.S. at 137. The effect on physical appearance
also should be considered. See Riggins, 504 U.S. at 137. It then is for the trial
court to determine if a defendant's right to a fair trial will be adversely affected.
Under Sell, the State has an important interest in "bringing to trial an
individual accused of a serious crime" but "special circumstances" might lessen
the importance of the State's interest. 539 U.S. at 180. In arguing that there
were no special circumstances that lessened the importance of the State's
interest, the State urges us to consider that the maximum sentence for this third-
degree crime is five years, and that because this was a crime of domestic
violence, the presumption of non-incarceration did not apply.
The federal circuit courts have differed on how to apply the first factor
under Sell: some rely on the maximum sentence for the charges to evaluate if
the crime is serious; others consider the defendant's probable sentence. 7
7
See, e.g., United States v. Gutierrez, 704 F.3d 442, 451 (5th Cir. 2013)
(following the approach for determining seriousness of a crime utilized by the
A-3090-18T3
18
We agree with the trial judge that Sell's first factor requires more than
simple consideration of the maximum sentence. The Supreme Court made clear
that a case-by-case approach is required. Sell, 539 U.S. at 180. If a trial court
only needed to consider the maximum length of the sentence, the Court would
not have mentioned the need to consider special circumstances—such as the
length of confinement, the potential for future confinement and jail credits to be
second, fourth, and tenth circuits, comparing the time the defendant has served
pre-trial to the statutory maximum); United States v. White, 620 F.3d 401, 410-
11 (4th Cir. 2010) (explaining that notwithstanding the seriousness of a crime,
special circumstances such as the time defendant has already been confined
compared to his expected sentence, can reduce the State's interest in prosecuting
a defendant); United States v. Nicklas, 623 F.3d 1175, 1178-80 (8th Cir. 2010)
(considering whether the defendant had served close to or more than his
probable sentence, to determine whether special circumstances militated against
the government's interest in prosecuting the defendant); United States v. Ruiz-
Gaxiola, 623 F.3d 684, 693-94 (9th Cir. 2010) (using the sentencing guideline
range for an offense, rather than the statutory maximum, as the starting point for
determining the seriousness of a crime); United States v. Green, 532 F.3d 538,
549 (6th Cir. 2008) (utilizing the maximum statutory penalty for a crime as an
objective means to assess seriousness); Gomes, 387 F.3d at 160-61 (finding that
certain circumstances, such as the potential for a lengthy period of civil
commitment which would diminish the risk of future crime, "may lessen the
importance" of the State's interest in prosecuting a defendant); United States v.
Weinberg, 743 F. Supp. 2d 234, 237 (W.D.N.Y. 2010) (providing that to
determine whether there is an important government interest, courts should first
consider the nature of the charge and the potential penalty, including the
statutory maximum and the sentencing guidelines range for the offense, and
then compare that to any period of pretrial incarceration).
A-3090-18T3
19
applied toward sentencing—all of which could reduce the State's interest in
prosecution.
We agree with the trial court that special circumstances lessened the
State's interest in this case. We have no reason to disagree with the trial court's
analysis that defendant might receive a probationary sentence if treated as a
third-degree offender, that his charges appeared to stem from his delusions and
he has remained at TPH longer than if convicted. The trial court correctly
considered the length of time defendant was confined, his possible need for
future confinement and potential jail credits.
We have every confidence that our criminal trial judges can evaluate a
defendant's probable sentence based on the charges, the understanding of our
sentencing guidelines and the application of probable aggravating and
mitigating factors. This approach also is consistent with the Court's
understanding that the need to medicate involuntarily to restore a defendant to
competency will be rare, which is our expectation as well.
Because we agree with the trial court that the State failed to satisfy the
first factor under Sell, we affirm the trial court's order that denied the State's
motion to require involuntary medication. We have no occasion to address
A-3090-18T3
20
whether our State's Constitution would afford defendant greater liberty or
privacy.
Affirmed.
A-3090-18T3
21